The Remarkable Remission: Navigating Life 17+ Years After a Follicular Lymphoma Diagnosis

• When did Bob get diagnosed? January 2008.
• When was his first treatment? January 2010.
• How often does he get a scan? He does not get routine scans; monitoring consists of physical exams and blood work.

For anyone navigating a cancer diagnosis, the future can feel uncertain. But for "Lympho Bob," a man diagnosed with Follicular Lymphoma (FL) in January 2008, the journey has been a lesson in patience, modern medicine, and the complex reality of living with an "incurable" disease. His story, spanning over 17 years, offers a powerful perspective on long-term remission and the evolving strategies for cancer surveillance.

Diagnosis and the "Watch and Wait" Two-Step

At 40 years old, Bob received the news: Follicular Lymphoma, stage 3, grade 1 and 2. The diagnosis came unexpectedly after a bout of pneumonia led to a CT scan that revealed swollen lymph nodes.

Like many with slow-growing lymphomas, his oncologist recommended an initial period of "Watch and Wait" (W&W). The thinking was simple: since the disease was considered incurable, it was better to delay the rigors of treatment until absolutely necessary. For two full years, Bob lived with the knowledge of his cancer without actively fighting it.

One Treatment, 15 Years of Freedom

Exactly two years to the day after his diagnosis, in January 2010, it was time to begin treatment. The weapon of choice was six rounds of Rituxan. The results were nothing short of astounding.

As of 2025, Bob has not required any further treatment. That single course of Rituxan has given him 15 years of extended remission. His oncologist calls it "remarkable" and even holds out hope that he may never need treatment again.

Redefining Surveillance: Life Without Scans

So, does Bob still have Follicular Lymphoma? The nuanced answer is yes. The disease is a part of his story, and a scan taken many years ago did show some evidence of it. However, he is living in a state of non-treatment, managed through careful surveillance—a strategy that has changed significantly over the years.

Bob has not had a routine scan in a very long time. This is a deliberate choice by his medical team for several key reasons:

1. Risk of Secondary Cancers: Oncologists are increasingly aware that repeated radiation exposure from CT scans over a lifetime carries a risk of causing new, secondary cancers.
2. Limited Impact on Survival: Research suggests that routine surveillance imaging for asymptomatic patients may not actually improve overall survival rates.
3. Treating the Patient, Not the Scan: The philosophy is to act when there are symptoms. If new signs of the disease were to emerge, the process would begin from scratch with a biopsy to confirm what's happening.

Instead of scans, Bob's monitoring consists of a physical exam and blood work with his oncologist every six months.

The Mental Game of an "Incurable" Disease

Living in long-term remission with a chronic cancer is also a psychological journey. Bob admits he thinks about Follicular Lymphoma every single day. He doesn't consider himself "cured," acknowledging the fear of recurrence that many survivors face when told their disease is likely to return.

Yet, despite this constant awareness, he lives his life "in many ways as if I'm cured," continuing to make long-term plans and embrace the future. His story is a testament to living fully and hopefully, even with uncertainty in the background. It's a powerful example of how managing a chronic cancer is as much about the mindset as it is about the medicine.